Literature DB >> 3581695

Systemic lupus erythematosus. Follow-up study of 148 patients. II: Predictive factors of importance for course and outcome.

P Halberg, B Alsbjørn, J T Balslev, I Lorenzen, J Gerstoft, S Ullman, A Wiik.   

Abstract

The predictive value of a number of clinical and laboratory variables for the mortality of 148 patients with systemic lupus erythematosus (SLE) with a mean observation period of 8 years and a 10-year-survival of 80 per cent was calculated by means of differentiated survival rate analyses and stepwise regression analyses. The predictive power of several variables increased if the calculations were based on deaths caused by SLE rather than on the total mortality rate. The survival rate decreased after 1973 because a diagnosis of SLE was made in some patients with terminal disease who would have remained without a diagnosis before that time. The causes of death and the treatment were identical before and after 1973. The presence of a high number of diagnostic ARA criteria within the first year of observation was a predictor of decreased survival. Severe but non-fatal infections (meningitis, septicemia, pneumonia) significantly reduced the survival rate. Patients with proteinuria and azotemia, within the first 2 years of observation, had a 10-year-survival of 70 per cent. The survival of patients with CNS manifestations was not significantly reduced. The butterfly rash and the presence of lymphopenia were predictors of decreased survival, whereas the presence of DNA antibodies had no predictive value for survival.

Entities:  

Mesh:

Year:  1987        PMID: 3581695     DOI: 10.1007/bf02200996

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  8 in total

1.  Significance of persisting serologic abnormalities in SLE.

Authors:  R W Lightfoot; G R Hughes
Journal:  Arthritis Rheum       Date:  1976 Sep-Oct

2.  Prognostic significance of subepidermal immune deposits in uninvolved skin of patients with systemic lupus erythematosus: a 10-year longitudinal study.

Authors:  B M Davis; J N Gilliam
Journal:  J Invest Dermatol       Date:  1984-10       Impact factor: 8.551

3.  The 1982 revised criteria for the classification of systemic lupus erythematosus.

Authors:  E M Tan; A S Cohen; J F Fries; A T Masi; D J McShane; N F Rothfield; J G Schaller; N Talal; R J Winchester
Journal:  Arthritis Rheum       Date:  1982-11

4.  Predictive value of anti-DNA antibody and selected laboratory studies in systemic lupus erythematosus.

Authors:  C L Ludivico; B Zweiman; A R Myers; J Hebert; P A Green
Journal:  J Rheumatol       Date:  1980 Nov-Dec       Impact factor: 4.666

5.  A multicenter study of outcome in systemic lupus erythematosus. I. Entry variables as predictors of prognosis.

Authors:  E M Ginzler; H S Diamond; M Weiner; M Schlesinger; J F Fries; C Wasner; T A Medsger; G Ziegler; J H Klippel; N M Hadler; D A Albert; E V Hess; G Spencer-Green; A Grayzel; D Worth; B H Hahn; E V Barnett
Journal:  Arthritis Rheum       Date:  1982-06

6.  Prognostic value of anti-dsDNA in SLE.

Authors:  A J Swaak; J Groenwold; L A Aarden; L W Statius van Eps; E W Feltkamp
Journal:  Ann Rheum Dis       Date:  1982-08       Impact factor: 19.103

7.  Systemic lupus erythematosus: follow-up study of 148 patients. I: Classification, clinical and laboratory findings, course and outcome.

Authors:  P Halberg; B Alsbjørn; J T Balsløv; J Gerstoft; I Lorenzen; S Ullman; A Wiik
Journal:  Clin Rheumatol       Date:  1987-03       Impact factor: 2.980

8.  The clinical significance of Raynaud's phenomenon in systemic lupus erythematosus.

Authors:  J Dimant; E Ginzler; M Schlesinger; G Sterba; H Diamond; D Kaplan; M Weiner
Journal:  Arthritis Rheum       Date:  1979-08
  8 in total
  8 in total

Review 1.  Infection-related morbidity and mortality in patients with connective tissue diseases: a systematic review.

Authors:  Matthew E Falagas; Katerina G Manta; Gregoria I Betsi; Georgios Pappas
Journal:  Clin Rheumatol       Date:  2006-12-21       Impact factor: 2.980

2.  A multicentre study of 513 Danish patients with systemic lupus erythematosus. II. Disease mortality and clinical factors of prognostic value.

Authors:  S Jacobsen; J Petersen; S Ullman; P Junker; A Voss; J M Rasmussen; U Tarp; L H Poulsen; G van Overeem Hansen; B Skaarup; T M Hansen; J Pødenphant; P Halberg
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

3.  Development and Verify of Survival Analysis Models for Chinese Patients With Systemic Lupus Erythematosus.

Authors:  Linyu Geng; Wenqiang Qu; Jun Liang; Wei Kong; Xue Xu; Wenyou Pan; Lin Liu; Min Wu; Fuwan Ding; Huaixia Hu; Xiang Ding; Hua Wei; Yaohong Zou; Xian Qian; Meimei Wang; Jian Wu; Juan Tao; Jun Tan; Zhanyun Da; Miaojia Zhang; Jing Li; Huayong Zhang; Xuebing Feng; Jiaqi Chen; Lingyun Sun
Journal:  Front Immunol       Date:  2022-06-24       Impact factor: 8.786

4.  A long-term immunological study of childhood onset systemic lupus erythematosus.

Authors:  C K Ting; K H Hsieh
Journal:  Ann Rheum Dis       Date:  1992-01       Impact factor: 19.103

5.  The actual survival rate in systemic lupus erythematosus: study of a 1976 cohort.

Authors:  M Breban; O Meyer; P Bourgeois; E Palazzo; M F Kahn
Journal:  Clin Rheumatol       Date:  1991-09       Impact factor: 2.980

6.  Systemic lupus erythematosus: follow-up study of 148 patients. I: Classification, clinical and laboratory findings, course and outcome.

Authors:  P Halberg; B Alsbjørn; J T Balsløv; J Gerstoft; I Lorenzen; S Ullman; A Wiik
Journal:  Clin Rheumatol       Date:  1987-03       Impact factor: 2.980

7.  Unusual eye manifestations in systemic lupus erythematosus patients.

Authors:  A A Drosos; C A Petris; G M Petroutsos; H M Moutsopoulos
Journal:  Clin Rheumatol       Date:  1989-03       Impact factor: 2.980

8.  Incidence and prevalence of lupus in Buenos Aires, Argentina: a 11-year health management organisation-based study.

Authors:  M Scolnik; J Marin; S M Valeiras; M F Marchese; A S Talani; N L Avellaneda; A Etchepare; P Etchepare; M S Plou; E R Soriano
Journal:  Lupus Sci Med       Date:  2014-06-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.